Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.51 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.50 |
| ▸ | CTSL | P07711 | 2/20 | 0.49 |
| ▸ | CTSS | P25774 | 2/20 | 0.49 |
| ▸ | CTSK | P43235 | 2/20 | 0.49 |
| ▸ | CTSH | P09668 | 1/20 | 0.49 |
| ▸ | APLNR | P35414 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29503865 | 0.88 | EPHA2 (0.58) | NMUR2NMUR1OPRM1OPRD1 | |
| SCHEMBL29695470 | 0.88 | OPRM1 (0.52) | NMUR2NMUR1OPRM1OPRD1APLNR | |
| SCHEMBL29570069 | 0.88 | NTSR2 (0.53) | NMUR2NMUR1APLNR | |
| SCHEMBL30775524 | 0.87 | F2 (0.56) | OPRM1OPRD1OPRK1APLNR | |
| SCHEMBL31558390 | 0.87 | F2 (0.56) | OPRM1OPRD1OPRK1APLNR | |
| SCHEMBL30974034 | 0.86 | EPHA2 (0.55) | NMUR2NMUR1OPRM1OPRD1OPRK1 | |
| SCHEMBL30974301 | 0.85 | OPRM1 (0.56) | NMUR2NMUR1OPRM1OPRD1OPRK1 | |
| SCHEMBL30011006 | 0.85 | SLC6A2 (0.54) | OPRM1OPRD1OPRK1APLNR | |
| SCHEMBL31014197 | 0.84 | MAPK8 (0.56) | NMUR2NMUR1OPRD1 | |
| SCHEMBL30248619 | 0.84 | MAPK8 (0.59) | NMUR2NMUR1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240352069-A1 | SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | SHENZHEN WINKEY TECHNOLOGY CO., LTD. (CN) | 2024-10-24 | — | — | US | claimed |
| EP-4385516-A1 | SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Shenzhen Winkey Technology Co., Ltd. (CN) | 2024-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240352069-A1 | SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | VIP, MC1R, PROKR1 | NMUR2 1890/4885NMUR1 1468/4885OPRM1 3299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.